Idexx Laboratories (IDXX) announced that Brian McKeon has decided to retire from Idexx effective June 1, 2025. Andrew Emerson, currently senior VP, corporate and companion animal group finance, will succeed McKeon as Idexx’s executive VP, CFO and treasurer, effective March 1, 2025. McKeon will serve as EVP and special advisor to the company from March 1, 2025 until his retirement from Idexx on June 1, 2025, to help ensure a transition.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IDXX:
- Idexx Laboratories Announces CEO Jonathan Ayers’ Resignation
- Idexx Laboratories price target lowered to $435 from $520 at Piper Sandler
- Idexx Laboratories price target lowered to $481 from $570 at Barclays
- IDEXX Laboratories Reports Robust Q3 2024 Performance
- Idexx Laboratories narrows 2024 EPS view to $10.37-$10.53 from $10.31-$10.59